In this study, we explored the expression of STYK1 and E-cadherin in pancreatic cancer, and analyzed the relationship between their expression levels and clinico-pathological features in the patients with pancreatic cancer. This evidence concerns the gene STYK1 and familial pancreatic carcinoma.